Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MZT1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | YIPF2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | PDSS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | GNL3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | BUB1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | TBC1D9B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | CBFB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | G6PC3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | DIMT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |